Inventor · disambiguated record
Hans-Willi Jansen
Also filed as: JANSEN HANS-WILLI
20 granted patents·6 pending applications·246 citations·filing 1997–2013
95Inventor score
Files withAVENTIS PHARMA GMBH13HOECHST AG4SANOFI AVENTIS DEUTSCHLAND4LICHER THOMAS2HOECHST MARION ROUSSEL DE GMBH1
Top patents by PatentIndex Score
26 records- 0190US6737423B2Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising themAVENTIS PHARMA GMBH·Filed 2001·Granted May 18, 2004·38 cites·34 claims
- 0289US6593352B2Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blockerAVENTIS PHARMA GMBH·Filed 2001·Granted Jul 15, 2003·41 cites·16 claims
- 0382US6451781B1Substituted acylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising themAVENTIS PHARMA GMBH·Filed 2000·Granted Sep 17, 2002·16 cites·9 claims
- 0478US6005010APhenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing themHOECHST AG·Filed 1997·Granted Dec 21, 1999·45 cites·21 claims
- 0575US6825231B2Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising themAVENTIS PHARMA GMBH·Filed 2000·Granted Nov 30, 2004·8 cites·37 claims
- 0675US6339077B1Substituted 4-benzylaminoquinolines and their hetero analogs, process for their preparation, pharmaceuticals containing these compounds and use thereofAVENTIS PHARMA GMBH·Filed 2000·Granted Jan 15, 2002·8 cites·10 claims
- 0772US7550257B2Process for identifying substances which modulate the activity of hyperpolarization-activated cation channelsSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Jun 23, 2009·1 cites·24 claims
- 0871US7442717B2Substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aidSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Oct 28, 2008·4 cites·11 claims
- 0971US6979532B2Process for identifying substances which modulate the activity of hyperpolarization-activated cation channelsAVENTIS PHARMA GMBH·Filed 2002·Granted Dec 27, 2005·6 cites·31 claims
- 1071US2009143473A1Use of inhibitors of the cellular na+/h+ exchanger (nhe) for preparing a medicament for normalizing serum lipidsSANOFI AVENTIS DEUTSCHLAND·Filed 2009·Application pending·0 cites
- 1170US6335451B1Five-membered heterocycles having biphenylsulfonyl substitution, with sulfonylcyanamide side chain, compositions containing them, and methods of using themHOECHST AG·Filed 1998·Granted Jan 1, 2002·26 cites·28 claims
- 1270US6291502B1Use of 2-imidazolyl-substituted carbinols for the production of a medicament for the treatment or phophylaxis of diseases caused by ischemic conditionsAVENTIS PHARMA GMBH·Filed 2000·Granted Sep 18, 2001·4 cites·9 claims
- 1365US6617344B2Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising themAVENTIS PHARMA GMBH·Filed 2003·Granted Sep 9, 2003·1 cites·15 claims
- 1465US6486189B2Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising themHOECHST AG·Filed 2001·Granted Nov 26, 2002·2 cites·12 claims
- 1565US5968978ABiphenylsulfonylcyanamides, process for their preparation, and their use as medicamentHOECHST MARION ROUSSEL DE GMBH·Filed 1998·Granted Oct 19, 1999·23 cites·18 claims
- 1660US2004122096A1Use of inhibitors of the cellular Na+/H+ exchanger (NHE) for preparing a medicament for normalizing serum lipidsHOECHST AG·Filed 2003·Application pending·0 cites
- 1759US8546102B2Methods for determining sodium-proton-exchanger ligand efficiencyLICHER THOMAS·Filed 2009·Granted Oct 1, 2013·1 cites·18 claims
- 1858US2008275098A1Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aidSANOFI AVENTIS DEUTSCHLAND·Filed 2008·Application pending·0 cites
- 1956US6166002ASubstituted phenylalkenoylguanidines, process for their preparation, and their use in medicaments and in diagnosticsAVENTIS PHARMA GMBH·Filed 1999·Granted Dec 26, 2000·14 cites·20 claims
- 2051US2002099222A1Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising themFiled 2002·Application pending·0 cites
- 2150US2014106366A1Methods for determining sodium-proton-exchanger ligand efficiencyLICHER THOMAS·Filed 2013·Application pending·0 cites
- 2249US2001049446A1Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising themFiled 2001·Application pending·0 cites
- 2343US6573288B1Substituted sulphonyl cyanamides, method for producing same and their use as medicamentAVENTIS PHARMA GMBH·Filed 1999·Granted Jun 3, 2003·5 cites·30 claims
- 2441US6331546B1Use of 2-amino-3,4-dihydroquinazolines for the production of a medicament for the treatment or prophylaxis of illnesses caused by ischemic conditionsAVENTIS PHARMA GMBH·Filed 2000·Granted Dec 18, 2001·0 cites·13 claims
- 2540US6703411B2Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing themAVENTIS PHARMA GMBH·Filed 2001·Granted Mar 9, 2004·0 cites·20 claims
- 2640US6369069B1Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicamentAVENTIS PHARMA GMBH·Filed 1999·Granted Apr 9, 2002·3 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when Hans-Willi Jansen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →